{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Suffern",
      "state": "NY",
      "country": "United States",
      "classification": "Class III",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "68815",
      "recalling_firm": "Novartis Pharmaceuticals Corp.",
      "address_1": "25 Old Mill Rd",
      "address_2": "N/A",
      "postal_code": "10901-4106",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide",
      "recall_number": "D-1516-2014",
      "product_description": "Cataflam (diclofenac potassium) tablets, 50 mg, 100-count bottles, Rx only, Manufactured by: Patheon Inc., Whitby Operations, Ontario, Canada L1N 5Z5; Distributed by: Novartis Pharmaceuticals Corp., East Hanover, New Jersey  07936; NDC 0078-0436-05, UPC 3 0078-0436-05 2.",
      "product_quantity": "50 bottles",
      "reason_for_recall": "Failed Tablet/Capsule Specifications: Ink identification had rubbed off tablets in transit making them illegible to pharmacists and consumers.",
      "recall_initiation_date": "20140730",
      "center_classification_date": "20140806",
      "termination_date": "20141205",
      "report_date": "20140813",
      "code_info": "Lot # PKTS, Exp 01/17"
    }
  ]
}